Recombinant proteins for COVID-19 research

Coronaviruses contain a non-segmented, positive-sense RNA genome and are known to affect humans, mammals, and birds. Coronavirus virus particles contain four main structural proteins. These are the spike (S), membrane (M), envelope (E), and nucleocapsid (N) proteins, all of which are encoded within the 3′ end of the viral genome.

The recent SARS-CoV-2 outbreak has stimulated research on coronaviruses thereby identifying a large number of antiviral target proteins such as viral proteases, polymerases, and entry proteins. However, significant research is still required to develop drugs that target these proteins and can inhibit viral replication. BioVision offers a variety of coronavirus recombinant proteins to support coronavirus research. Additionally, Biovision offers numerous other coronavirus research tools including Antibodies, Assay kits, Antiviral agents etc.

Recombinant proteins for COVID-19 research

Key Features

  • Highly pure
  • Source: Expressed in E.coli , CHO cells or Human cells.
  • Versatile: Can be used for multiple applications

SDS-PAGE of Recombinant SARS-CoV-2 Spike Protein S1 (Cat. No. P1540)

Below are few highlighted SARS-CoV-2 proteins available from BioVision:

Product Name

Cat. No.

Size

Human CellExp™ SARS-CoV-2 Spike Protein (RBD), (R)

P1530

10 µg, 50 µg

Human CellExp™ SARS-CoV-2 Spike Protein (S1), ( R)

P1531

10 µg, 50 µg

Human CellExp™ SARS-CoV-2 Spike Protein (S1; His-tag), (R)

P1532

10 µg, 50 µg

Recombinant SARS-CoV-2 Nucleoprotein (1-430)

P1537

10 µg, 50 µg

Recombinant SARS-CoV-2 Nucleoprotein (1-430)

P1539

10 µg, 50 µg

Recombinant SARS-CoV-2 Nucleoprotein (1-430, His-tag)

P1536

10 µg, 50 µg

Recombinant SARS-CoV-2 Nucleoprotein (1-430; His-tag)

P1538

10 µg, 50 µg

Recombinant SARS-CoV-2 Spike Protein S1 (Fc tag)

P1541

10 µg, 50 µg

SDS-PAGE of Recombinant SARS-CoV-2 Spike Protein S1

P1540

10 µg, 50 µg

Click here to see the complete list of COVID-19 Research Tools from BioVision & the corresponding flyer.

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BioVision Incorporated. (2020, May 05). Recombinant proteins for COVID-19 research. News-Medical. Retrieved on September 21, 2020 from https://www.news-medical.net/news/20200505/Recombinant-proteins-for-COVID-19-research.aspx.

  • MLA

    BioVision Incorporated. "Recombinant proteins for COVID-19 research". News-Medical. 21 September 2020. <https://www.news-medical.net/news/20200505/Recombinant-proteins-for-COVID-19-research.aspx>.

  • Chicago

    BioVision Incorporated. "Recombinant proteins for COVID-19 research". News-Medical. https://www.news-medical.net/news/20200505/Recombinant-proteins-for-COVID-19-research.aspx. (accessed September 21, 2020).

  • Harvard

    BioVision Incorporated. 2020. Recombinant proteins for COVID-19 research. News-Medical, viewed 21 September 2020, https://www.news-medical.net/news/20200505/Recombinant-proteins-for-COVID-19-research.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.